The Food and Drug Administration just won a court case supporting the agency's ability to regulate stem cell clinics that rely on client-derived adipose tissues. This is a win for consumer protection, though too late to help those already harmed.
Three patients were treated with a slurry of stem cells and blood products, in both eyes, on the same day. Could the outcome, three patients becoming legally blind, have been foreseen? Probably.